Development and evaluation of Radical Oxygen Species (ROS)-responsive drug delivery systems to prevent and cure inflammatory and hypoxic diseases.

Project Information

ROSCURE-O2

Grant agreement ID: 101153515

DOI

10.3030/101153515

Project closed

EC signature date 17 April 2024

Start date 1 September 2024

End date 31 August 2026

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost

No data

EU contribution

€ 165 312,96

Coordinated by

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.

Publications

Peer reviewed articles (3)

Extracellular matrix remodeling therapeutic strategies to tackle central nervous system diseases

Author(s): Daniel A. Domingo-Lopez, Maria Rosa Aguilar de Armas, Sergio Martin-Saldaña
Published in: Neural Regeneration Research, Issue 21, 2026, ISSN 1673-5374
Publisher: Ovid Technologies (Wolters Kluwer Health)
DOI: 10.4103/NRR.NRR-D-25-01562

Viologen redox polymers for NADH-free alcohol dehydrogenase bioelectrocatalysis: Structure–activity relationships and mechanistic insight

Author(s): Kavita Jayakumar, Mihai-Cristian Fera, P.Yeray Pernia-Blazquez, Daniel A. Domingo-Lopez, Antonio L. De Lacey's, Marcos Pita
Published in: Electrochimica Acta, Issue 577, 2026, ISSN 0013-4686
Publisher: Elsevier BV
DOI: 10.1016/J.ELECTACTA.2026.149736

From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics

Author(s): John Gostage, Daniel A. Domingo-Lopez, Ruth Tarpey, Garry P. Duffy, Ruth E. Levey
Published in: Molecular Therapy Methods & Clinical Development, Issue 33, 2026, ISSN 2329-0501
Publisher: Elsevier BV
DOI: 10.1016/J.OMTM.2025.101613

Book chapters (1)

Osteochondral Angiogenesis and Promoted Vascularization: New Therapeutic Target

Author(s): Daniel A. Domingo-Lopez, Luis García-Fernández
Published in: Osteochondral Tissue Engineering, 2026
Publisher: Springer Nature Switzerland
DOI: 10.1007/978-3-031-80976-7_14-1